Verona Pharma Plc

This study is testing whether a new inhaled medicine called ensifentrine can reduce harmful inflammation in the lungs of people with COPD. 56 participants with moderate to severe COPD will use the medicine or a placebo inhaler twice daily for 8-week periods, with researchers meas…

This study is testing whether an inhaled medicine called ensifentrine can help control a chronic lung disease called bronchiectasis. About 180 adults with this condition will use a nebulizer twice daily for at least 24 weeks, receiving either the real medicine or a placebo. The m…

This study is testing a new inhaled combination of two medicines (ensifentrine and glycopyrrolate) for people with Chronic Obstructive Pulmonary Disease (COPD). Researchers want to see if taking the two drugs together works better than taking either one alone or a placebo at impr…